Luvira
- Product NDC
- 69336-349
- 11-digit product format
- 693360349
- Labeler code
- 69336
- Product ID
- 69336-349_baf70922-8fa4-491d-bd45-f0f985def69e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Luvira
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Sterling-Knight Pharmaceuticals, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2020-01-17
- Marketing end
- 0000-00-00
- Substance
- OMEGA-3 FATTY ACIDS; 12-HYDROXYEICOSAPENTAENOIC ACID, (12R)-; 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, (4E,7E,10E,13E,16E,19E)-
- Active strength
- 1220 mg/1; mg/1; mg/1
- Pharmacologic classes
- Fatty Acids, Omega-3 [CS],Omega-3 Fatty Acid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69336-349-90 | Luvira | 90 in 1 BOTTLE | CAPSULE | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69336-349 | LUVIRA CAPSULE [STERLING-KNIGHT PHARMACEUTICALS, LLC] | 2 | Legacy NDC, 1 package rows | 20200129_9f38aea7-4e56-42fc-99d6-c964a9f26205.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69336-349-90 | 69336034990 | 90 CAPSULE in 1 BOTTLE (69336-349-90) | 90 capsule | 2020-01-17 | 0000-00-00 | No | No | Current |